AI-Powered Medical Research & Drug Discovery
AI is compressing the time and cost of bringing new therapies to patients by learning the “rules” of biology and chemistry, generating targets and molecules, and optimizing preclinical to clinical decisions—while new regulatory guidance clarifies how AI evidence can support approvals in 2025. Biological foundation models, generative chemistry/protein design, and closed‑loop robotics are moving from … Read more